Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

MoonLake Immunotherapeutics (MLTX) Interest & Investment Income (2021 - 2022)

MoonLake Immunotherapeutics' Interest & Investment Income history spans 2 years, with the latest figure at $8431.0 for Q1 2022.

  • Quarterly Interest & Investment Income fell 52.67% to $8431.0 in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $18307.0 through Mar 2022, changed N/A year-over-year, with the annual reading at $27691.0 for FY2021, 85.63% up from the prior year.
  • Interest & Investment Income came in at $8431.0 for Q1 2022, up from $2255.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $17815.0 in Q1 2021 to a low of $1481.0 in Q3 2021.